Page last updated: 2024-08-21

lithocholic acid and Cholangiitis, Sclerosing

lithocholic acid has been researched along with Cholangiitis, Sclerosing in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Befeler, A; Keach, J; Kowdley, KV; Lindor, K; Marschall, HU; Sinakos, E	1
Befeler, AS; Eaton, JE; Harnois, D; Harrison, ME; Jorgensen, R; Kowdley, KV; Lindor, KD; Luketic, VA; McCashland, T; Pardi, DS; Petz, J; Silveira, MG; Sinakos, E	1
Beuers, U; Paumgartner, G; Sauter, G	1

Trials

1 trial(s) available for lithocholic acid and Cholangiitis, Sclerosing

Article	Year
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. The American journal of gastroenterology, 2011, Volume: 106, Issue:9 Topics: Adolescent; Adult; Aged; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Lithocholic Acid; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk; Ursodeoxycholic Acid; Young Adult	2011

Article

Year

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

The American journal of gastroenterology, 2011, Volume: 106, Issue:9

Topics: Adolescent; Adult; Aged; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Lithocholic Acid; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk; Ursodeoxycholic Acid; Young Adult

2011

Other Studies

2 other study(ies) available for lithocholic acid and Cholangiitis, Sclerosing

Article	Year
Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:1 Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lithocholic Acid; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2010
Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver disease under ursodeoxycholic acid therapy. Digestion, 1995, Volume: 56, Issue:6 Topics: Adult; Aged; Bile Acids and Salts; Cholangitis, Sclerosing; Chronic Disease; Dietary Fiber; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Psyllium; Ursodeoxycholic Acid	1995

Article

Year

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.

Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:1

Topics: Adolescent; Adult; Aged; Bile Acids and Salts; Cholagogues and Choleretics; Cholangitis, Sclerosing; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lithocholic Acid; Male; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid; Young Adult

2010

Effect of dietary fiber on serum bile acids in patients with chronic cholestatic liver disease under ursodeoxycholic acid therapy.

Digestion, 1995, Volume: 56, Issue:6

Topics: Adult; Aged; Bile Acids and Salts; Cholangitis, Sclerosing; Chronic Disease; Dietary Fiber; Female; Humans; Lithocholic Acid; Liver Cirrhosis, Biliary; Male; Middle Aged; Psyllium; Ursodeoxycholic Acid

1995